218632-36-1

Basic information

• Product Name: ETHYL 1-(4-METHOXYPHENYL)-3-METHYL-1H-PYRAZOLE-5-CARBOXYLATE
• Synonyms: BUTTPARK 85\18-77;ETHYL 1-(4-METHOXYPHENYL)-3-METHYL-1H-PYRAZOLE-5-CARBOXYLATE;1-(4-METHOXYPHENYL)-3-METHYL-1H-PYRAZOLE-5-CARBOXYLATE;1-(4-Methoxyphenyl)-3-methyl-1H-pyrazole-5-carboxylic acid ethyl ester
• CAS NO: 218632-36-1
• Molecular Formula: C₁₄H₁₆N₂O₃
• Molecular Weight: 260.29
• Mol File: 218632-36-1.mol

Chemical Properties

• Appearance: /
• Density: 1.16
• Storage Temp.: 2-8°C
• CAS DataBase Reference: ETHYL 1-(4-METHOXYPHENYL)-3-METHYL-1H-PYRAZOLE-5-CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: ETHYL 1-(4-METHOXYPHENYL)-3-METHYL-1H-PYRAZOLE-5-CARBOXYLATE(218632-36-1)
• EPA Substance Registry System: ETHYL 1-(4-METHOXYPHENYL)-3-METHYL-1H-PYRAZOLE-5-CARBOXYLATE(218632-36-1)

Safety Data

• Hazardous Substances Data: 218632-36-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Development:
ETHYL 1-(4-METHOXYPHENYL)-3-METHYL-1H-PYRAZOLE-5-CARBOXYLATE is used as a key intermediate in the synthesis of various pharmaceuticals for the treatment of different diseases and medical conditions. Its unique structure and properties make it a valuable component in drug discovery and development processes.
Used in Organic Synthesis:
In the field of organic synthesis, ETHYL 1-(4-METHOXYPHENYL)-3-METHYL-1H-PYRAZOLE-5-CARBOXYLATE is used as a versatile building block for the creation of complex organic molecules. Its reactivity and functional groups allow for a wide range of chemical reactions, facilitating the synthesis of novel compounds with potential applications in various industries.
Used in Medicinal Chemistry Research:
ETHYL 1-(4-METHOXYPHENYL)-3-METHYL-1H-PYRAZOLE-5-CARBOXYLATE is utilized in medicinal chemistry research to explore its potential as a therapeutic agent or as a structural component in the design of new drugs. Its unique properties and structure make it an attractive candidate for the development of innovative pharmaceuticals.
Used in Drug Discovery:
In the drug discovery process, ETHYL 1-(4-METHOXYPHENYL)-3-METHYL-1H-PYRAZOLE-5-CARBOXYLATE is employed as a starting material or a modifying agent to create new drug candidates. Its chemical properties and structural features contribute to the development of compounds with improved pharmacological profiles and therapeutic potential.
Used in Bioactive Compound Development:
ETHYL 1-(4-METHOXYPHENYL)-3-METHYL-1H-PYRAZOLE-5-CARBOXYLATE is used as a precursor in the development of bioactive compounds with potential applications in various industries, such as agriculture, cosmetics, and pharmaceuticals. Its versatility and reactivity enable the synthesis of a diverse range of bioactive molecules with specific biological activities.

Upstream product

• 98790-58-0 ethyl (Z)-4-hydroxy-2-oxopent-3-enoate 
• 3471-32-7 4-Methoxyphenylhydrazine 
• 615-79-2 ethyl 2,4-diketopentanoate 
• 19501-58-7 4-methoxyphenylhydrazine hydrochloride 
• 82874-96-2 2-methoxyimino-4-oxo-pentaneperoxoic acid ethyl ester 

Downstream Products

• 1448994-18-0 2-(2-(5-fluorouracil-1-yl)acetamido)ethyl 1-(4-methoxyphenyl)-3-methyl-1H-pyrazole-5-carboxylate 
• 946859-63-8 2-(4-Hydroxyphenyl)-5-methyl-2H-pyrazole-3-carboxylic acid-ethyl ester 
• 218631-44-8 1-(4-methoxyphenyl)-3-methyl-1H-pyrazole-5-carboxylic acid 
• 218629-72-2 2-(4-methoxy-phenyl)-5-methyl-2H-pyrazole-3-carboxylic acid (2'-sulfamoyl-biphenyl-4-yl)-amide 
• 218631-46-0 2-(4-methoxy-phenyl)-5-methyl-2H-pyrazole-3-carboxylic acid (2'-tert-butylsulfamoyl-3-fluoro-biphenyl-4-yl)-amide 
• 1026441-12-2 2-(4-methoxy-phenyl)-5-methyl-2H-pyrazole-3-carboxylic acid (2'-tert-butylsulfamoyl-biphenyl-4-yl)-amide 
• 1026272-62-7 2-(4-methoxy-phenyl)-5-methyl-2H-pyrazole-3-carboxylic acid [5-(2-tert-butylsulfamoyl-phenyl)-pyridin-2-yl]-amide 
• 1351169-51-1 1-(4-methoxyphenyl)-3-methyl-N-(1H-tetrazol-5-yl)-1H-pyrazole-5-carboxamide 
• 1019007-97-6 2-(4-methoxyphenyl)-5-methyl-2H-pyrazole-3-carboxylic acid chloride 

Relevant articles and documents

PYRAZOLOPYRIDAZINE DERIVATIVES, PREPARATION METHOD THEREOF AND COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING THE SAME

The present invention is a pyrazolopyridazine derivative. A pharmaceutical composition for preventing or treating cancer contains the pyrazolopyridazin derivative compound Hsp90 according to the present invention as an active ingredient, which can be used as Hsp90 a pharmaceutical composition for preventing or treating Hsp90-related diseases such as melanoma, brain tumor, breast cancer, lung cancer and the like. (by machine translation)

Design and Synthesis of Imidazole and Triazole Pyrazoles as Mycobacterium Tuberculosis CYP121A1 Inhibitors

The emergence of untreatable drug-resistant strains of Mycobacterium tuberculosis is a major public health problem worldwide, and the identification of new efficient treatments is urgently needed. Mycobacterium tuberculosis cytochrome P450 CYP121A1 is a p

Microwave-assisted synthesis of tetrazolyl pyrazole amides

A rapid and efficient microwave-assisted synthesis N-(1H-tetrazol-5-yl) derivatives of 3-methyl-1-phenyl-1H-pyrazole- 5-carboxamide is described. These tetrazole pyrazole amides have interesting bacteriocidal, pesticidal, herbicidal and antimicrobial activities. They were identified by IR and 1H NMR elemental analyses. The target compounds were obtained in a shorter reaction time compared to conventional heating methods.

Pyrazoles for the treatment of obesity and other CNS disorders

This invention relates to compounds having pharmacological activity, to compositions containing these compounds, and to a method of treatment employing the compounds and compositions. More particularly, this invention concerns certain pyrazole derivatives, their salts and solvates. These compounds have H3 histamine receptor binding activity. This invention also relates to pharmaceutical compositions containing these compounds and to a method of treating disorders in which histamine H3 receptor modulation is beneficial.

Discovery of 1-(2-Aminomethylphenyl)-3-trifluoromethyl-N-[3-fluoro-2′ -(aminosulfonyl)[1,1′-biphenyl)]-4-yl]-1H-pyrazole-5-carboxyamide (DPC602), a Potent, Selective, and Orally Bioavailable Factor Xa Inhibitor

Factor Xa, a serine protease, is at the critical juncture between the intrinsic and extrinsic pathways of the coagulation cascade. Inhibition of factor Xa has the potential to provide effective treatment for both venous and arterial thrombosis. We recentl